Skip Navigation


Human Molecular Genetics Advance Access originally published online on December 6, 2007
Human Molecular Genetics 2008 17(5):759-767; doi:10.1093/hmg/ddm348
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
17/5/759    most recent
ddm348v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Williams, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Williams, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease

Yonghong Li1, Andrew Grupe1,*, Charles Rowland1, Peter Holmans2, Ricardo Segurado2, Richard Abraham2, Lesley Jones2, Joseph Catanese1, David Ross1, Kevin Mayo3, Maribel Martinez3, Paul Hollingworth2, Alison Goate3,4,5, Nigel J. Cairns4,6, Brad A. Racette4, Joel S. Perlmutter4,7,8, Michael C. O'Donovan2, John C. Morris3,6, Carol Brayne9, David C. Rubinsztein9, Simon Lovestone10, Leon J. Thal11,{dagger}, Michael J. Owen2 and Julie Williams2

1 Celera, 1401 Harbor Bay Parkway, Alameda, CA 94502, USA 2 Department of Psychological Medicine & Biostatistics and Bioinformatics Unit, Wales School of Medicine, Cardiff University, Cardiff CF14 4XN, UK 3 Department of Psychiatry 4 Department of Neurology 5 Department of Genetics 6 Department of Pathology & Immunology 7 Department of Radiology and 8 Department of Anatomy & Neurobiology, Washington University School of Medicine, St Louis, MO 63110, USA 9 Department of Medical Genetics, University of Cambridge, Cambridge Institute for Medical Research, Addenbrookés Hospital, Cambridge CB2 2XY, UK 10 MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College London, London SE5 8AF, UK and 11 Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA

* To whom correspondence should be addressed. Tel: +1 5107496222; Fax: +1 5107496286; Email: andrew.grupe{at}celera.com

Received September 21, 2007; Revised November 21, 2007; Accepted November 26, 2007

Late-onset Alzheimer's disease (LOAD) and Parkinson's disease (PD) are the most common neurodegenerative disorders and in both diseases susceptibility is known to be influenced by genes. We set out to identify novel susceptibility genes for LOAD by performing a large scale, multi-tiered association study testing 4692 single nucleotide polymorphism (SNPs). We identified a SNP within a putative transcription factor binding site in the NEDD9 gene (neural precursor cell expressed, developmentally down-regulated), that shows good evidence of association with disease risk in four out of five LOAD samples [N = 3521, P = 5.38x10–6, odds ratio (OR) = 1.38 (1.20–1.59)] and in addition, we observed a similar pattern of association in two PD sample sets [N = 1464, P = 0.0145, OR =1.31 (1.05–1.62)]. In exploring a potential mechanism for the association, we observed that expression of NEDD9 and APOE show a strong inverse correlation in the hippocampus of Alzheimer's cases. These data implicate NEDD9 as a novel susceptibility gene for LOAD and possibly PD.

{dagger} This paper is dedicated to the memory of Leon Thal for his many contributions to Alzheimer's research and patient therapy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
J. Chapuis, F. Moisan, G. Mellick, A. Elbaz, P. Silburn, F. Pasquier, D. Hannequin, C. Lendon, D. Campion, P. Amouyel, et al.
Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease
Hum. Mol. Genet., September 15, 2008; 17(18): 2863 - 2867.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.